Nuvo Pharmaceuticals Inc. (OTCMKTS:MRVFF) (TSX:MRV) Stock Continues to Trade in a Narrow Range

Nuvo Pharmaceuticals Inc. (OTCMKTS:MRVFF) (TSX:MRV) d/b/a Miravo Healthcare is moving in a range after announcing that it has been listed to the 2022 OTCQX Best 50 is the ranking of the best performing firms listed in the OTCQX Best Market in 2021.

Market Stats

On Monday, MRVFF stock ended flat at $1.05 with more than 3.9k shares, compared to its average volume of 2.88k shares. The stock has moved within a range of $1.0500 – 1.0500 after opening trading at $1.05.   

Miravo Healthcare™ Named to 2022 OTCQX Best 50

The annual OTCQX Best 50 ranking considers the top 50 United States and international firms listed on the OTCQX platform. The ranking is determined by giving a one-year return rate and daily average dollar volume increase in the previous fiscal year. The OTCQX Best 50 for 2022 were chosen based on merit in 2021.

CEO and President Jesse Ledger said they are delighted to be part of the 2022 OTCQX Best 50 ranking at number 39. Ledger said the achievement comes following commitment and hard work by the Miravbo team in 2021 and continued execution of the company’s strategic plan. Interestingly to qualify for listing, companies have to meet financial standards with the best corporate governance practice. So in the coming weeks, investors should watch MRVFF.

Key Quote

“We are very pleased to be included in the 2022 OTCQX Best 50 at #39,” said Jesse Ledger, Miravo’s President and CEO. “This achievement comes as a result of the dedication and hard work Miravo employees have made during 2021, as we continued to execute on our strategic plan.”

Traders Corner

MRVFF stock is trading below the 50-Day and 100-Day Moving averages of $1.07 and $1.15 respectively. The stock is trading in neutral zone with the RSI at 38.